About – Dr Bhavesh Poladia
Dr. Bhavesh Poladia is a highly skilled medical oncologist practicing at the Thangam Cancer Centre in Namakkal, Tamil Nadu with more than 20+ years of experience in this field. With a deep commitment to providing exceptional care to cancer patients, Dr. Poladia specializes in the diagnosis, treatment, and management of various types of cancer. He is known for his expertise in medical interventions such as chemotherapy, immunotherapy, targeted therapy, and hormone therapy, tailored to meet the individual needs of each patient.
Specialization
Dr.Bhavesh Poladia specializes in a wide range of specific medical capability interventions
- Surgical Oncology
- Uro Oncology
- Radiation Oncology
- Medical Oncology
- Onco Pathology
- Onco Rehabilitation
- Nephrology
- Surgical Gastroenterology
- Pain and Palliation
Education
- 2015 – Homi Bhabha National Institute, DM Medical Oncology, Tata Memorial Hospital (TMH), Mumbai.
- 2010 – National Board of Examination – DNB General Medicine, Lilavati Hospital and Research Centre, Mumbai.
- 2003 – Grant Medical College & Sir J.J.Group of Hospitals, Mumbai.
Career
- Jan 2004 to Dec 2004 – Grant Medical College & Sir J.J. Group of Hospitals, Mumbai.
- August 2006 to July 2010 – General Medicine department in Lilavati Hospital and Research Centre, Mumbai.
- August 2010 To July 2016 – Medical Oncology department in Tata Memorial Hospital (TMH), Mumbai.
- September 2016 till date – Thangam Hospital and Thangam Cancer Centre, Namakkal, Tamilnadu.
Research Projects
- As a contributing author in ‘Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer – An Indian exploratory analysis study’ South Asian Journal of Cancer, January 2019.
- As a contributing author in ‘Docetaxel/Oxaliplatin/Capecitabine (TEX) triplet followed by continuation monotherapy in advanced gastric cancer’ Indian Journal of Cancer, January 2018.
- As a contributing author in ‘Outcome of metastatic neuroendocrine tumors with Cap-Tem regimen: A retrospective tertiary care center analysis’ Digestive Surgery, January 2016.
- As a contributing author in ‘Retrospective Analysis of Prospective Database Assessing the Efficacy and Tolerability of First Line Docetaxel Based Chemotherapy Followed by Docetaxel or Capecitabine Maintenance in Non-progressive, Metastatic stomach adenocarcinoma-Experience from tertiary referral centre’ Digestive Surgery, January 2016.
- As a first author in ‘Development of hyponatremia on neoadjuvant chemotherapy in locally advanced head & neck cancers’ Conference Paper in ESMO, January 2013.
- As a contributing author in ‘Epidemiology of oral cancers referred for NACT, the demographics, clinical profile, and organ functions’ Conference Paper in ASCO, January 2013.
- As a contributing author in ‘Induction Chemotherapy in Locally Advanced Pharyngolaryngeal Cancers with Stridor: Is It Feasible and Safe?’ Chemotherapy Research and Practice, August 2012.
- As a contributing author in ‘Unusual coexistence of renal anomaly and germ cell tumour: An embryonal happenstance?’ Indian Journal of Medical and Paediatric Oncology, July 2012.
- As a second author in ‘Hyperammonemic Coma Presenting as Hashimoto’s Encephalopathy’ Journal of the Association of Physicians of India, October 2008.
Dr. Poladia is a well-known oncologist dedicated to staying at the forefront of oncology research and treatment advancements, ensuring that his patients receive the most effective and cutting-edge care available. His compassionate approach and unwavering dedication to improving patient outcomes have earned him respect and admiration among both his colleagues and patients.